Changes underlying arrhythmia in the transgenic heart overexpressing Refsum disease gene-associated protein

Biochemical and Biophysical Research Communications

Volumn 313, Issue 1, 2004, Pages 156-162

  Koh, Jeong Tae ^a   Jeong, Byung Chul ^a   Kim, Jae Ha ^b   Ahn, Young Keun ^a   Lee, Hyang Sim ^b   Baik, Yung Hong ^b   Kim, Kyung Keun ^b  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Aconitine; Arrhythmia; PAHX AP1; Propranolol; Refsum disease; Tachycardia; Transgenic mouse

Indexed keywords

ACONITINE; BETA 1 ADRENERGIC RECEPTOR; ION CHANNEL; MUSCARINIC RECEPTOR; PHYTANOYL COENZYME A ALPHA HYDROXYLASE TRANSCRIPTION FACTOR AP 1; PROPRANOLOL; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTROPHYSIOLOGY; GENE OVEREXPRESSION; HEART ARRHYTHMIA; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REFSUM DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0346220221     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.105     Document Type: Article

References (28)

1. Lee Z.H., Kim H., Ahn K.Y., Seo K.H., Kim J.K., Bae C.S., Kim K.K. Identification of a brain specific protein that associates with a Refsum disease gene product, phytanoyl-CoA alpha-hydroxylase. Mol. Brain Res. 75:2000;237-247.
2. Koh J.T., Choi H.H., Ahn K.Y., Kim J.U., Kim J.H., Chun J.Y., Baik Y.H., Kim K.K. Cardiac characteristics of transgenic mice overexpressing Refsum disease gene-associated protein within the heart. Biochem. Biophys. Res. Commun. 286:2001;1107-1116.
3. Khodorov B.I. Batrachotoxin as a tool to study voltage-sensitive sodium channels of excitable membranes. Prog. Biophys. Mol. Biol. 45:1985;57-148.
4. Catterall W.A. Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu. Rev. Pharmacol. Toxicol. 20:1980;15-43.
5. Kimura I., Makino M., Takamura Y., Islam M.A., Kimura M. Positive chronotropic and inotropic effects of higenamine and its enhancing action on the aconitine-induced tachyarrhythmia in isolated murine atria. Jpn. J. Pharmacol. 66:1994;75-80.
6. Kimura I., Islam M.A., Kimura M. Potentiation by higenamine of the aconitine-induced positive chronotropic effect in isolated right atria of mice: the effects of cholera toxin, forskolin and pertussis toxin. Biol. Pharm. Bull. 19:1996;1032-1037.
7. 2+ transport and contractility. J. Mol. Cell. Cardiol. 30:1998;1991-2002.
8. 2+ on aconitine-induced arrhythmias. Jpn. Heart J. 37:1996;709-718.
9. Janse M.J., Opthof T., Kleber A.G. Animal models of cardiac arrhythmias. Cardiovasc. Res. 39:1998;165-177.
10. Nattel S. Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc. Res. 42:1999;298-308.
11. Nattel S., Li D. Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ. Res. 87:2000;440-447.
12. Van Wagoner D.R., Nerbonne J.M. Molecular basis of electrical remodeling in atrial fibrillation. J. Mol. Cell. Cardiol. 32:2000;1101-1117.
13. 2+-channel, beta-adrenorecptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation. Basic Res. Cardiol. 96:2001;82-90.
14. Tanaka R., Fulbright B.M., Mukherjee R., Burchell S.A., Crawford F.A., Zile M.R., Spinale F.G. The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. J. Mol. Cell. Cardiol. 25:1993;1215-1233.
15. Hedberg A., Isaksson O., Lundgren B. Sustained cardiac beta adrenoceptor blockade in vitro and increased vulnerability to aconitine-induced arrhythmias in vivo after propranolol withdrawal in rats. J. Pharmacol. Exp. Ther. 214:1980;664-669.
16. Yue L., Melnyk P., Gaspo R., Wang Z., Nattel S. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ. Res. 84:1999;776-784.
17. Van Gelder I.C., Brundel B.J., Henning R.H., Tuinenburg A.E., Tieleman R.G., Deelman L., Grandjean J.G., De Kam P.J., Van Gilst W.H., Crijns H.J. Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 10:1999;552-560.
18. Brundel B.J., van Gelder I.C., Henning R.H., Tuinenburg A.E., Deelman L.E., Tieleman R.G., Grandjean J.G., van Gilst W.H., Crijns H.J. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc. Res. 42:1999;443-454.
19. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J. Am. Coll. Cardiol. 33:1999;1231-1237.
20. Grammer J.B., Bosch R.F., Kuhlkamp V., Seipel L. Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J. Cardiovasc. Electrophysiol. 11:2000;626-633.
21. + channels in rat atrium: electrical remodeling in paroxysmal atrial tachycardia. Circulation. 101:2000;2007-2014.
22. Roden D.M., George A.L. Structure and function of cardiac sodium and potassium channels. Am. J. Physiol. 273:1997;H511-H525.
23. Rolf S., Haverkamp W., Borggrefe M., Musshoff U., Eckardt L., Mergenthaler J., Snyders D.J., Pongs O., Speckmann E.J., Breithardt G., Madeja M. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes. Naunyn Schmiedebergs Arch. Pharmacol. 362:2000;22-31.
24. Madeja M., Leicher T., Friederich P., Punke M.A., Haverkamp W., Musshoff U., Breithardt G., Speckmann E.J. Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1. Mol. Pharmacol. 63:2003;547-556.
25. + current. Circulation. 103:2001;1317-1324.
26. Yeih D.F., Chiang F.T., Huang S.K. Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone. Heart. 84:2000;e8.
27. Coumel P. Autonomic influences in atrial tachyarrhythmias. J. Cardiovasc. Electrophysiol. 7:1996;999-1007.
28. Steinbeck G., Hoffmann E. 'True' atrial tachycardia. Eur. Heart J. 19:1998;E10-E12. see also pp. E48-E49.